BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 21470216)

  • 1. Acne inversa successfully treated with infliximab.
    von Preussen AC; Flux K; Hartschuh W; Hartmann M
    Int J Dermatol; 2012 Aug; 51(8):1011-3. PubMed ID: 21470216
    [No Abstract]   [Full Text] [Related]  

  • 2. Acne inversa treated with infliximab: different outcomes in 2 patients.
    Antonucci A; Negosanti M; Negosanti L; Iozzo I; Varotti C
    Acta Derm Venereol; 2008; 88(3):274-5. PubMed ID: 18480930
    [No Abstract]   [Full Text] [Related]  

  • 3. Long-term efficacy of a single course of infliximab in hidradenitis suppurativa.
    Mekkes JR; Bos JD
    Br J Dermatol; 2008 Feb; 158(2):370-4. PubMed ID: 18047504
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of severe hidradenitis suppurativa with infliximab in combination with surgical interventions.
    Van Rappard DC; Mekkes JR
    Br J Dermatol; 2012 Jul; 167(1):206-8. PubMed ID: 22229974
    [No Abstract]   [Full Text] [Related]  

  • 5. Paradoxical effect of infliximab in a patient with hidradenitis suppurativa.
    Gori A; Rossari S; Bruscino N; Tripo L
    Dermatol Ther; 2012; 25(4):376-8. PubMed ID: 22950564
    [No Abstract]   [Full Text] [Related]  

  • 6. Severe hidradenitis suppurativa treated with infliximab infusion.
    Adams DR; Gordon KB; Devenyi AG; Ioffreda MD
    Arch Dermatol; 2003 Dec; 139(12):1540-2. PubMed ID: 14676068
    [No Abstract]   [Full Text] [Related]  

  • 7. Axillary hidradenitis suppurativa successfully treated with infliximab in a Crohn's disease patient.
    Katsanos KH; Christodoulou DK; Tsianos EV
    Am J Gastroenterol; 2002 Aug; 97(8):2155-6. PubMed ID: 12190206
    [No Abstract]   [Full Text] [Related]  

  • 8. Treatment of hidradenitis suppurativa with infliximab in a patient with Crohn's disease.
    Rosi YL; Lowe L; Kang S
    J Dermatolog Treat; 2005 Feb; 16(1):58-61. PubMed ID: 15897171
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term infliximab for severe hidradenitis suppurativa.
    Thielen AM; Barde C; Saurat JH
    Br J Dermatol; 2006 Nov; 155(5):1105-7. PubMed ID: 17034567
    [No Abstract]   [Full Text] [Related]  

  • 10. Treatment of hidradenitis suppurativa with tumour necrosis factor-alpha inhibitors: An update on infliximab.
    Brunasso AM; Massone C
    Acta Derm Venereol; 2011 Jan; 91(1):70-1. PubMed ID: 21103830
    [No Abstract]   [Full Text] [Related]  

  • 11. Hidradenitis suppurativa responding to treatment with infliximab.
    Lasocki A; Sinclair R; Foley P; Saunders H
    Australas J Dermatol; 2010 Aug; 51(3):186-90. PubMed ID: 20695857
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Variable response of hidradenitis suppurativa to infliximab in four patients.
    Usmani N; Clayton TH; Everett S; Goodfield MD
    Clin Exp Dermatol; 2007 Mar; 32(2):204-5. PubMed ID: 17342798
    [No Abstract]   [Full Text] [Related]  

  • 13. Infliximab therapy for patients with moderate to severe hidradenitis suppurativa: a randomized, double-blind, placebo-controlled crossover trial.
    Grant A; Gonzalez T; Montgomery MO; Cardenas V; Kerdel FA
    J Am Acad Dermatol; 2010 Feb; 62(2):205-17. PubMed ID: 20115947
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of hidradenitis suppurativa with infliximab.
    Torres T; Selores M
    An Bras Dermatol; 2010; 85(4):576. PubMed ID: 20944927
    [No Abstract]   [Full Text] [Related]  

  • 15. Efficacy and tolerance of prolonged infliximab treatment of moderate-to-severe forms of hidradenitis suppurativa.
    Lesage C; Adnot-Desanlis L; Perceau G; Bonnet M; Palot JP; Bernard P; Reguiaï Z
    Eur J Dermatol; 2012; 22(5):640-4. PubMed ID: 22759562
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interleukin 6 and high-sensitivity C-reactive protein are potential predictive markers of response to infliximab in hidradenitis suppurativa.
    Montaudié H; Seitz-Polski B; Cornille A; Benzaken S; Lacour JP; Passeron T
    J Am Acad Dermatol; 2017 Jan; 76(1):156-158. PubMed ID: 27986139
    [No Abstract]   [Full Text] [Related]  

  • 17. SAPHO syndrome associated with hidradenitis suppurativa successfully treated with infliximab and methotrexate.
    De Souza A; Solomon GE; Strober BE
    Bull NYU Hosp Jt Dis; 2011; 69(2):185-7. PubMed ID: 22035400
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy of infliximab for hidradenitis suppurativa: assessment of clinical and biological inflammatory markers.
    Delage M; Samimi M; Atlan M; Machet L; Lorette G; Maruani A
    Acta Derm Venereol; 2011 Mar; 91(2):169-71. PubMed ID: 21384087
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term efficacy of infliximab in hidradenitis suppurativa.
    Paradela S; Rodríguez-Lojo R; Fernández-Torres R; Arévalo P; Fonseca E
    J Dermatolog Treat; 2012 Aug; 23(4):278-83. PubMed ID: 22482700
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pyoderma gangrenosum, acne conglobata, suppurative hidradenitis, and axial spondyloarthritis: efficacy of anti-tumor necrosis factor α therapy.
    Bruzzese V
    J Clin Rheumatol; 2012 Dec; 18(8):413-5. PubMed ID: 23188209
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.